SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

Insider at Dexcom (DXCM) Makes Significant Sale of Stock

· 02/04/2021 17:27

10:19 PM EST, 02/04/2021 (MT Newswires) -- There was a notable sale of shares of Dexcom by an insider today, as revealed in a form 4 document filed with the SEC. One insider -- Kevin R Sayer, Director and Officer -- sold 12,468 shares in the company having a market value of approximately $4,714,965. There have been 8 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the sale of 77,958 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 90,426 shares and have averaged 10,047 shares per transaction over this time period.

The number of insider buy/sell trades at Dexcom is above that of the 93 peer company average over the last 90-day period. The Medical Equipment, Supplies & Distribution peer group saw 87 buy/sell trades during this period for an average of 0.9 transactions per company. However, the number of shares traded per transaction by Dexcom insiders is lower than its peers. Within the peer group there were 94,306 shares purchased and 1,724,225 shares sold with company insiders having sold 18,735 shares on average over this time period.

In order to focus on significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated from data sourced to compose and write this story.

[Disclaimer]
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.